EICHORCondition: Advanced Solid Tumor · Sponsor: OncoC4, Inc.
BIPAVE-001 is a Phase 1-2 study for evaluating the safety, pharmacokinetics (PK), and efficacy of AI-081 in solid tumors.
This description comes directly from the study's public registry record.
Pan Zheng, MD, PhD · 2027516823 · pzheng@oncoc4.com
Kazu Kai, MD · kkai@oncoc4.com
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| Highlands Oncology Group | Springdale, Arkansas, United States | Recruiting |
| MedStar Georgetown University Hospital | Washington D.C., District of Columbia, United States | Recruiting |
| University of Florida UF Health Cancer Center | Gainesville, Florida, United States | Recruiting |
| Memorial Healthcare System | Hollywood, Florida, United States | Recruiting |
| Ocala Oncology Center PL DBA Florida Cancer Affiliates | Ocala, Florida, United States | Recruiting |
| AdventHealth Cancer Institute | Orlando, Florida, United States | Recruiting |
| Northwestern University | Chicago, Illinois, United States | Recruiting |
| Norton Cancer Center | Louisville, Kentucky, United States | Recruiting |
| Dana-Farber Cancer Institute | Boston, Massachusetts, United States | Recruiting |
| University of Michigan Rogel Cancer Center | Ann Arbor, Michigan, United States | Recruiting |
| Henry Ford Health | Detroit, Michigan, United States | Recruiting |
+ 7 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06635785